Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

776 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study.
Fox P, Balleine RL, Lee C, Gao B, Balakrishnar B, Menzies AM, Yeap SH, Ali SS, Gebski V, Provan P, Coulter S, Liddle C, Hui R, Kefford R, Lynch J, Wong M, Wilcken N, Gurney H. Fox P, et al. Among authors: ali ss. Clin Cancer Res. 2016 Jul 1;22(13):3164-71. doi: 10.1158/1078-0432.CCR-15-1470. Epub 2016 Feb 4. Clin Cancer Res. 2016. PMID: 26847054 Clinical Trial.
Metformin in prostate cancer: two for the price of one.
Clements A, Gao B, Yeap SHO, Wong MKY, Ali SS, Gurney H. Clements A, et al. Among authors: ali ss. Ann Oncol. 2011 Dec;22(12):2556-2560. doi: 10.1093/annonc/mdr037. Epub 2011 Mar 18. Ann Oncol. 2011. PMID: 21421541 Free article. Review.
G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma.
Kelly GM, Al-Ejeh F, McCuaig R, Casciello F, Ahmad Kamal N, Ferguson B, Pritchard AL, Ali S, Silva IP, Wilmott JS, Long GV, Scolyer RA, Rao S, Hayward NK, Gannon F, Lee JS. Kelly GM, et al. Clin Cancer Res. 2021 May 1;27(9):2624-2635. doi: 10.1158/1078-0432.CCR-20-3463. Epub 2021 Feb 15. Clin Cancer Res. 2021. PMID: 33589432
Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II).
Atkinson V, Sandhu S, Hospers G, Long GV, Aglietta M, Ferrucci PF, Tulyte S, Cappellini GCA, Soriano V, Ali S, Poprach A, Cesas A, Rodriguez-Abreu D, Lau M, de Jong E, Legenne P, Stein D, King B, van Thienen JV. Atkinson V, et al. Melanoma Res. 2020 Jun;30(3):261-267. doi: 10.1097/CMR.0000000000000654. Melanoma Res. 2020. PMID: 31895752
Prognostic Utility of CDX2 and PD-L1 in Rectal Cancer.
Shahnam A, Paver E, Nguyen B, Fadia M, Ali S. Shahnam A, et al. Appl Immunohistochem Mol Morphol. 2020 Jul;28(6):e53. doi: 10.1097/PAI.0000000000000752. Appl Immunohistochem Mol Morphol. 2020. PMID: 31166198 No abstract available.
776 results